@prefix this: . @prefix sub: . @prefix beldoc: . @prefix rdfs: . @prefix xsd: . @prefix dct: . @prefix dce: . @prefix pav: . @prefix np: . @prefix prov: . @prefix Protein: . @prefix hgnc: . @prefix geneProductOf: . @prefix hasPart: . @prefix ProteinComplex: . @prefix species: . @prefix occursIn: . @prefix pubmed: . @prefix orcid: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { sub:_1 hasPart: hgnc:6547, sub:_2; occursIn: species:9606; a ProteinComplex: . sub:_2 geneProductOf: hgnc:6204; a Protein: . sub:assertion rdfs:label "complex(p(HGNC:JUN),g(HGNC:LDLR))" . } sub:provenance { beldoc: dce:description "Approximately 61,000 statements."; dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved."; dce:title "BEL Framework Large Corpus Document"; pav:authoredBy sub:_4; pav:version "1.4" . sub:_3 prov:value "Three DNA-protein complexes (C1, C3 and C4) were detected in control extracts and 4 complexes (C1, C2, C3 and C4) were detected in oncostatin M (OM)-treated nuclear extracts using a P32-labeled oligonucleotide probe (TATA1+2) containing LDLR promoter sequence -25 to +5. EMSA studies demonstrated that the C1 complex was completely supershifted by anti-c-Jun antibodies but none of these antibodies affected the C2 complex. The data suggest that the C1 complex may be a heterodimer of ATF and c-Jun; c-Jun is not present in the C2 complex. Additional gel shift assays using control extract showed a weaker supershift band with anti-c-Jun antibodies compared to the OM-treated extract, suggesting that OM stimulation may increase the c-Jun DNA-binding activity."; prov:wasQuotedFrom pubmed:10671569 . sub:_4 rdfs:label "Selventa" . sub:assertion prov:hadPrimarySource pubmed:10671569; prov:wasDerivedFrom beldoc:, sub:_3 . } sub:pubinfo { this: dct:created "2014-07-03T14:29:49.971+02:00"^^xsd:dateTime; pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 . }